• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524US
Device Problems Obstruction of Flow (2423); Infusion or Flow Problem (2964); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Obstruction/Occlusion (2422); Thromboembolism (2654); Thrombosis/Thrombus (4440)
Event Date 01/03/2022
Event Type  Injury  
Event Description
It was reported that an echocardiogram revealed a possible aortic leaflet thrombus and an arterial peripheral thromboembolism.The plan was for target inr (international normalized ratio) to be slightly elevated at 2.5.
 
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer's investigation is completed.
 
Event Description
The patient's antithrombotic medication would be intensified.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: the relevant sections of the device history record for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate 3 left ventricular assist system (hm 3 lvas) instructions for use (ifu) is currently available.Section 1, ("introduction") lists potential adverse events that may be associated with the use of the hm3 lvas, including thrombus and arterial peripheral thromboembolism.Section 6, (¿patient care and management¿), lists potential late postimplant complications that may be associated with the use of the hm3 lvas, including thromboembolism, as well as provides information regarding anticoagulation, including the recommended international normalized ratio (inr) values.A direct correlation between the reported thrombus and heartmate 3 (hm3) left ventricular assist device (lvad) serial number (b)(6) could not be conclusively determined through this evaluation.The patient remains ongoing with heartmate 3 left ventricular assist system, serial number (b)(6), and no product is available for investigation.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key13208134
MDR Text Key286526876
Report Number2916596-2022-00124
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 02/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/10/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/10/2023
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number8129962
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received02/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/13/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age76 YR
Patient SexMale
Patient Weight77 KG
-
-